En-bloc resection achieves higher GTR rates with similar neurological outcomes in grade-2 intramedullary spinal ependymomas: single-centre cohort study
- 3 February 2026
- journal article
- Published by Taylor & Francis in British Journal Of Neurosurgery
- p. 1-15
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Targeting the MYCN-MDM2 pathways for cancer therapy: Are they druggable?Genes & Diseases, 2025
- Clinical presentation and extent of resection impacts progression-free survival in spinal ependymomasJournal of Neuro-Oncology, 2024
- Impact of tumor-associated syrinx on outcomes following resection of primary ependymomas of the spinal cordJournal of Neuro-Oncology, 2022
- MYCN amplification drives an aggressive form of spinal ependymomaActa Neuropathologica, 2019
- Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical BehaviorJournal of Neuropathology & Experimental Neurology, 2019
- Intramedullary ependymoma: long-term outcome after surgeryActa Neurochirurgica, 2017
- Gross total resection rates of grade II/III intramedullary ependymomas using the surgical strategy of en-bloc resection without intra-operative neurophysiological monitoringBritish Journal Of Neurosurgery, 2016
- Improving spinal cord monitoring: A neurosurgeon’s viewClinical Neurophysiology, 2009
- Radial glia cells are candidate stem cells of ependymomaCancer Cell, 2005
- EpendymomasCurrent Neurology and Neuroscience Reports, 2003